P3‐411: Safety and pharmacokinetics of CHF5074, a novel gamma‐secretase modulator, after single oral administration to healthy humans
Bruno P. Imbimbo(Chiesi (France)), Joel Ross(Eaton (United States)), Laura Calzà(University of Bologna), Dottie Norris, Mercedes Fernández(University of Ferrara), Massimo Breda(Nerviano Medical Sciences), Karen Wagner(Agricultural Research Service), Luciana Giardino, E. Frigerio, Tara Aponte(Eaton (United States)), Donna Mackintosh(Eaton (United States))
Cited by 1
Related Papers
Endocrine Disrupters: A Review of Some Sources, Effects, and Mechanisms of Actions on Behaviour and Neuroendocrine Systems
|Journal of Neuroendocrinology|2011|425
An Updated Review of Ciguatera Fish Poisoning: Clinical, Epidemiological, Environmental, and Public Health Management
|Marine Drugs|2017|336
Ciguatera Fish Poisoning: Treatment, Prevention and Management
|Marine Drugs|2008|256
TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection
|Microorganisms|2021|196
Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome
|Journal of Neuroscience|2010|190